cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Seelos Therapeutics Inc
16 own
17 watching
Current Price
$0.86
$-0.02
(-2.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
92.16M
52-Week High
52-Week High
1.52
52-Week Low
52-Week Low
0.4803
Average Volume
Average Volume
0.69M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization92.16M
icon52-Week High1.52
icon52-Week Low0.4803
iconAverage Volume0.69M
iconDividend Yield--
iconP/E Ratio--
What does the Seelos Therapeutics Inc do?
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company s lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
Read More
How much money does Seelos Therapeutics Inc make?
News & Events about Seelos Therapeutics Inc.
PR Newswire
1month ago
Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event Seelos Therapeutics to Participate in the 12th Annual LifeSci Partners Corporate Access Event PR Newswire NEW YORK, Dec. 22, 2022 NEW YORK, Dec. 22, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq...
PR Newswire
2 months ago
Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 Seelos Therapeutics to Hold a Research and Development Update Conference Call and Webcast on December 15, 2022 PR Newswire NEW YORK, Nov. 23, 2022 NEW YORK, Nov. 23, 2022 /PRNewswire...
PR Newswire
3 months ago
Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day PR Newswire NEW YORK, Nov. 7, 2022 NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq...
PR Newswire
4 months ago
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease PR Newswire NEW YORK, Oct. 5, 2022 FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Oct. 5, 2022...
PR Newswire
4 months ago
Seelos Therapeutics to Collaborate with the Healey & AMG Center for ALS in an Expanded Access Program Funded by a Grant from the National Institute of Neurological Disorders and Stroke under the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS) Seelos Therapeutics to...
Frequently Asked Questions
Frequently Asked Questions
What is Seelos Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Seelos Therapeutics Inc shares?
plus_minus_icon
How can I buy Seelos Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Seelos Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Seelos Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Seelos Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Seelos Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Seelos Therapeutics Inc?
plus_minus_icon
What percentage is Seelos Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Seelos Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.86
$-0.02
(-2.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00